Affiliation
University Hospital in Krakow; National Institute of Geriatrics, Rheumatology and Rehabilitation; Danylo Halytsky Lviv National Medical University; The Dudley Group NHS Foundation Trust.Publication date
01/10/2023
Metadata
Show full item recordAbstract
Cardiovascular disease is a major cause of morbidity and mortality in rheumatic diseases, particularly rheumatoid arthritis and systemic lupus erythematosus. Timely detection and monitoring of cardiovascular affections by advanced visualization techniques may improve outcomes across most rheumatic diseases. Although high-grade inflammation and (auto)immune pathways are well known for their negative effects on the heart and vasculature, cardiovascular risk estimation remains one of the unresolved critical issues in rheumatic diseases. The issue is complicated further in view of the latest reports on enhanced atherogenesis in the setting of fibromyalgia and osteoarthritis, where inflammation is seemingly not a major pathogenic factor. The intensity of systemic inflammation has been associated with major vascular events in some large cohort studies of inflammatory rheumatic diseases. Experts advocate for tight control of systemic inflammation and modifiable cardiovascular risk factors for reducing the overall risk of vascular events. Increasing patients' and specialists' knowledge and skills in cardiovascular monitoring and prevention is warranted to solve some of the cardiovascular issues in rheumatic diseases. Key Points Cardiovascular issues are prevalent across all age groups of patients with rheumatic diseases. Large cohort studies suggest that the intensity of systemic inflammation is a powerful predictor of vascular events in rheumatic diseases. Reliable and widely tested tools for predicting vascular events in inflammatory rheumatic diseases are currently unavailable. Empowering patients with rheumatic diseases and first-contact specialists with knowledge and skills to monitor and reduce cardiovascular risk factors' effects is a promising strategy. 2023. International League of Associations for Rheumatology (ILAR).Citation
Zimba O, Gasparyan AY. Cardiovascular issues in rheumatic diseases. Clin Rheumatol. 2023 Oct;42(10):2535-2539. doi: 10.1007/s10067-023-06656-y. Epub 2023 Jun 3. PMID: 37269421.Type
ArticlePMID
37269421Journal
Clinical RheumatologyPublisher
Springerae974a485f413a2113503eed53cd6c53
10.1007/s10067-023-06656-y